Intravenous administration of psoralen

{
  "publication_number": "US5618662A",
  "country": "US",
  "kind": "A",
  "title": "Intravenous administration of psoralen",
  "abstract": "Intravenous administration of 8-methoxypsoralen is disclosed, and more specifically intravenous administration of 8-methoxypsoralen-blood preparations, including platelets. Random donor platelet bags are treated, stored and pooled prior to transfusion.",
  "claims": [
    "1. A method of intravenous administration of a pooled treated platelet preparation, comprising: a) providing, in any order, i) a patient having a body weight measured in kilograms, ii) a plurality of random donor platelet bags between four and eight in number containing approximately three hundred milliliters of platelet rich plasma, iii) an aqueous salt solution comprising 8-methoxypsoralen, and iv) means for activating said 8-methoxypsoralen; b) centrifuging said platelet bags to concentrate said platelets and create platelet poor plasma; c) removing a portion of said platelet poor plasma and adding said aqueous salt solution to each of said bags such that said platelets are resuspended in a mixture having a residual plasma concentration between approximately eight and twenty-five percent by volume and having a concentration of approximately five micrograms of 8-methoxypsoralen per milliliter; and d) activating said 8-methoxypsoralen in said mixture in each of said bags with said means for activating said 8-methoxypsoralen, without causing significant damage to said platelets, to create a plurality of treated platelet preparations; e) storing said plurality of treated platelet preparations at approximately room temperature; f) pooling said plurality of treated platelet preparations to create a pooled treated platelet preparation for intravenous infusion; and g) administering said pooled treated platelet preparation by intravenous infusion to said patient at a rate of between approximately 1.0 and 10 milliliters per kilogram per hour.",
    "2. The method of claim 1, wherein said storing is for between 24 hours and five days.",
    "3. The method of claim 1, wherein said activating means comprises a photoactivation device which emits a given intensity of a spectrum of electromagnetic radiation comprising wavelengths between 320 nm and 380 nm.",
    "4. The method of claim 3, wherein said intensity is between one and 25 mW/cm 2.",
    "5. The method of claim 4, wherein said platelet preparation is exposed to said intensity for between one and ten minutes."
  ],
  "cpc": [
    "A01N 1/10",
    "A01N 1/12",
    "A01N 1/124",
    "A01N 43/90",
    "A61K 31/365",
    "A61K 31/37",
    "A61K 35/19",
    "A61K 41/0066",
    "A61K 41/17",
    "A61L 2/02",
    "A61L 2/18",
    "A61L 2103/05",
    "A61M 1/3616",
    "A61M 1/3681",
    "A61M 1/3683",
    "A61M 1/3686",
    "A61M 2202/0425",
    "A61M 2205/053",
    "A61N 5/06",
    "A61N 5/062"
  ],
  "assignees": [
    "CERUS CORP"
  ],
  "filing_date": "1994-01-21",
  "publication_date": "1997-04-08",
  "grant_date": "1997-04-08",
  "priority_date": "1992-03-02",
  "application_number": "US-18401694-A",
  "family_id": "22675257",
  "citations": [
    "US4124598A",
    "US4157723A",
    "US4169204A",
    "US4196281A",
    "US4265280A",
    "US4390619A",
    "US4412835A",
    "US4447415A",
    "US4695460A",
    "US4704352A",
    "US4727027A",
    "US4748120A",
    "US4828976A",
    "US4878891A",
    "US4925665A",
    "US4960408A",
    "US4992363A",
    "US5288605A",
    "USRE32874E"
  ]
}